Delivery Order SPE2DB20D7061-SPE2DB24FSMU1
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,095.92 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4559359814 - Metronidazole Gel, Vaginal, a pharmaceutical product, with a period of performance through January 11, 2023. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,755.21 firm fixed-price delivery order is for the provision of METRONIDAZOLE TOPICAL 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,640.11 delivery order is for the procurement of 60 gram tubes of 1% metronidazole topical gel, with a period of performance ending on March 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DOD) and Department of Veterans...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Metronidazole 0.75% cream in 45-gram units, valued at $1,590.68. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carried no set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.38 firm fixed-price delivery order is for 4,565,217,898 units of the pharmaceutical drug Metronidazole 250 mg tablets. The award has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.25 delivery order contract is for the supply of Metronidazole 500 mg tablets, a medication used to treat certain bacterial and parasitic infections. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,300 to Amerisourcebergen Drug Corporation for the supply of 4562001899 Metronidazole Topical 0.75% gel packets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 45 grams of the prescribed medication to fulfill requirements under the contract. The single delivery is to occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania between August 30 and 31, 2023. No set aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metronidazole 0.75% Cream in 45-gram quantities, with a ceiling value of $5,747.10 and a firm fixed-price structure. This non-set-aside award is scheduled for completion by August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader relationship with...
- This federal contract award, valued at $3,429.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Metronidazole 500 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,044.27 to AmerisourceBergen Drug Corp for the supply of Metronidazole 500 mg tablets (500-count packages) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSMU1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,703.22 firm fixed price delivery order is for Metronidazole Topical 1% Gel, a pharmaceutical product, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/22/24 |